Serotonin receptors and suicide, major depression, alcohol use disorder and reported early life adversity

Mark D Underwood, Suham A Kassir, Mihran J Bakalian, Hanga Galfalvy, Andrew J Dwork, J John Mann, Victoria Arango, Mark D Underwood, Suham A Kassir, Mihran J Bakalian, Hanga Galfalvy, Andrew J Dwork, J John Mann, Victoria Arango

Abstract

Serotonin neurotransmitter deficits are reported in suicide, major depressive disorder (MDD) and alcohol use disorder (AUD). To compare pathophysiology in these disorders, we mapped brain serotonin transporter (SERT), 5-HT1A, and 5-HT2A receptor binding throughout prefrontal cortex and in anterior cingulate cortex postmortem. Cases and controls died suddenly minimizing agonal effects and had a postmortem interval ≤24 h to avoid compromised brain integrity. Neuropathology and toxicology confirmed absence of neuropathology and psychotropic medications. For most subjects (167 of 232), a DSM-IV Axis I diagnosis was made by psychological autopsy. Autoradiography was performed in right hemisphere coronal sections at a pre-genual level. Linear model analyses included sex and age with group and Brodmann area as interaction terms. SERT binding was lower in suicides (p = 0.004) independent of sex (females < males, p < 0.0001), however, the lower SERT binding was dependent on MDD diagnosis (p = 0.014). Higher SERT binding was associated with diagnosis of alcoholism (p = 0.012). 5-HT1A binding was greater in suicides (p < 0.001), independent of MDD (p = 0.168). Alcoholism was associated with higher 5-HT1A binding (p < 0.001) but only in suicides (p < 0.001). 5-HT2A binding was greater in suicides (p < 0.001) only when including MDD (p = 0.117) and alcoholism (p = 0.148) in the model. Reported childhood adversity was associated with higher SERT and 5-HT1A binding (p = 0.004) in nonsuicides and higher 5-HT2A binding (p < 0.001). Low SERT and more 5-HT1A and 5-HT2A binding in the neocortex in depressed suicides is dependent on Axis I diagnosis and reported childhood adversity. Findings in alcoholism differed from those in depression and suicide indicating a distinct serotonin system pathophysiology.

Conflict of interest statement

J.M. receives royalties for the commercial use of the C-SSRS from the Research Foundation for Mental Hygiene. V.A., M.D.U. A.J.D. S.A.K., M.J.B. declare that they have no conflict of interest.

Figures

Fig. 1. Representative autoradiograms of receptor binding…
Fig. 1. Representative autoradiograms of receptor binding of [3H]-Cyanoimipramine to the serotonin transporter (left), [3H]-8-OH-DPAT to the 5-HT1A receptor (center) and [3H]-Ketanserin to the 5-HT2A receptor (right).
The autoradiograms are from sections cut from the right hemisphere of a representative nonpsychiatric control. The upper row has images of total binding, the middle row is of nonspecific binding and the lower row has subtracted images of specific binding. See methods for displacers and assay conditions. The images were calibrated to fmol/mg tissue using radioactivity standards and color-mapped to a single scale on the right
Fig. 2. Serotonin transporter (SERT) binding in…
Fig. 2. Serotonin transporter (SERT) binding in the prefrontal cortex.
A suicide and major depressive disorder (MDD), B alcohol use disorder and C early life adversity (ELA). SERT sites were labeled with [3H]-Cyanoimipramine. Note that: SERT is less in depressed suicide decedents and with MDD. With AUD there is more SERT but only in suicides, and there is more in ELA but only in nonsuicides. Values are expressed as mean ± SEM
Fig. 3. 5-HT 1A receptor binding in…
Fig. 3. 5-HT1A receptor binding in the prefrontal cortex.
A suicide and major depressive disorder (MDD), B alcohol use disorder and C early life adversity (ELA). 5-HT1A receptors were labeled with [3H]-8-OH-DPAT. There is no data for BA8 or BA24 for MDD nonsuicides because there was only one case with these regions. Note: 5-HT1A binding was greater in suicides independent of MDD, AUD was associated with higher 5-HT1A binding but only in suicides, and ELA is associated with more 5-HT1A receptor binding. Values are expressed as mean ± SEM
Fig. 4. 5-HT 2A receptor binding in…
Fig. 4. 5-HT2A receptor binding in the prefrontal cortex.
A suicide and major depressive disorder (MDD), B alcohol use disorder and C early life adversity (ELA). 5-HT2A receptors were labeled with [3H]-Ketanserin. Note that: there is more 5-HT2A binding in suicides but no difference with MDD; there is more binding in AUD and ELA, but only in suicides. Values are expressed as mean ± SEM

References

    1. van Heeringen K, Mann JJ. The neurobiology of suicide. Lancet Psychiatry. 2014;1:63–72. doi: 10.1016/S2215-0366(14)70220-2.
    1. Mann JJ, Arango V. Suicide: An Unnecessary Death. 2nd edn. Oxford OX2 6DP, United Kingdom: Oxford; 2015.
    1. LeMarquand D, Pihl RO, Benkelfat C. Serotonin and alcohol intake, abuse, and dependence: clinical evidence. Biol. Psychiatry. 1994;36:326–337. doi: 10.1016/0006-3223(94)90630-0.
    1. Underwood MD, Mann JJ, Arango V. Serotonergic and noradrenergic neurobiology of alcoholic suicide. Alcohol. Clin. Exp. Res. 2004;28:57s–69s. doi: 10.1097/.
    1. Pompili M, et al. Suicidal behavior and alcohol abuse. Int. J. Environ. Res. Public Health. 2010;7:1392–1431. doi: 10.3390/ijerph7041392.
    1. Becker A, Ehret AM, Kirsch P. From the neurobiological basis of comorbid alcohol dependence and depression to psychological treatment strategies: study protocol of a randomized controlled trial. BMC Psychiatry. 2017;17:153. doi: 10.1186/s12888-017-1324-0.
    1. Johnson JG, et al. Childhood adversities, interpersonal difficulties, and risk for suicide attempts during late adolescence and early adulthood. Arch. Gen. Psychiatry. 2002;59:741–749. doi: 10.1001/archpsyc.59.8.741.
    1. Enns MW, et al. Childhood adversities and risk for suicidal ideation and attempts: a longitudinal population-based study. Psychol. Med. 2006;36:1769–1778. doi: 10.1017/S0033291706008646.
    1. Caspi A, et al. Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science. 2003;301:386–389. doi: 10.1126/science.1083968.
    1. Labonte, B., Turecki, G. in The Neurobiological Basis of Suicide (ed Dwivedi, Y.) 275–296 (CRC Press, Boca Raton, 2012).
    1. Yang BZ, et al. Child abuse and epigenetic mechanisms of disease risk. Am. J. Prev. Med. 2013;44:101–107. doi: 10.1016/j.amepre.2012.10.012.
    1. Furczyk K, Schutová B, Michel TM, Thome J, Büttner A. The neurobiology of suicide - A review of post-mortem studies. J. Mol. Psychiatry. 2013;1:2. doi: 10.1186/2049-9256-1-2.
    1. Lewis DA. The human brain revisited. Opportunities and challenges in postmortem studies of psychiatric disorders. Neuropsychopharmacology. 2002;26:143–154. doi: 10.1016/S0893-133X(01)00393-1.
    1. Prabhakaran J, et al. Synthesis, in vitro and in vivo evaluation of [11C]MMTP: a potential PET ligand for mGluR1 receptors. Bioorg. Med. Chem. Lett. 2010;20:3499–3501. doi: 10.1016/j.bmcl.2010.04.146.
    1. Savitz JB, Drevets WC. Neuroreceptor imaging in depression. Neurobiol. Dis. 2013;52:49–65. doi: 10.1016/j.nbd.2012.06.001.
    1. Sullivan GM, et al. Positron emission tomography quantification of serotonin(1A) receptor binding in suicide attempters with major depressive disorder. JAMA Psychiatry. 2015;72:169–178. doi: 10.1001/jamapsychiatry.2014.2406.
    1. Meyer JH, et al. Prefrontal cortex 5-HT2 receptors in depression: an [18F]setoperone PET imaging study. Am. J. Psychiatry. 1999;156:1029–1034.
    1. Audenaert K, Peremans K, Goethals I, van Heeringen C. Functional imaging, serotonin and the suicidal brain. Acta Neurol. Belg. 2006;106:125–131.
    1. Parsey RV, et al. Lower serotonin transporter binding potential in the human brain during major depressive episodes. Am. J. Psychiatry. 2006;163:52–58. doi: 10.1176/appi.ajp.163.1.52.
    1. Miller JM, et al. Positron emission tomography quantification of serotonin transporter in suicide attempters with major depressive disorder. Biol. Psychiatry. 2013;74:287–295. doi: 10.1016/j.biopsych.2013.01.024.
    1. Yeh YW, et al. Incongruent reduction of serotonin transporter associated with suicide attempts in patients with major depressive disorder: a positron emission tomography study with 4-[18F]-ADAM. Int. J. Neuropsychopharmacol. 2014;18:pyu065.
    1. Oquendo MA, et al. Positron emission tomographic imaging of the serotonergic system and prediction of risk and lethality of future suicidal behavior. JAMA Psychiatry. 2016;73:1048–1055. doi: 10.1001/jamapsychiatry.2016.1478.
    1. Malone KM, Corbitt EM, Li S, Mann JJ. Prolactin response to fenfluramine and suicide attempt lethality in major depression. Br. J. Psychiatry. 1996;168:324–329. doi: 10.1192/bjp.168.3.324.
    1. Mann JJ, Malone KM. Cerebrospinal fluid amines and higher-lethality suicide attempts in depressed inpatients. Biol. Psychiatry. 1997;41:162–171. doi: 10.1016/S0006-3223(96)00217-X.
    1. Oquendo MA, et al. Positron emission tomography of regional brain metabolic responses to a serotonergic challenge and lethality of suicide attempts in major depression. Arch. Gen. Psychiatry. 2003;60:14–22. doi: 10.1001/archpsyc.60.1.14.
    1. Arango V, Underwood MD, Gubbi AV, Mann JJ. Localized alterations in pre- and postsynaptic serotonin binding sites in the ventrolateral prefrontal cortex of suicide victims. Brain Res. 1995;688:121–133. doi: 10.1016/0006-8993(95)00523-S.
    1. Underwood MD, et al. Neuron density and serotonin receptor binding in prefrontal cortex in suicide. Int. J. Neuropsychopharmacol. 2012;15:435–447. doi: 10.1017/S1461145711000691.
    1. Arango V, et al. Autoradiographic Demonstration of Increased Serotonin 5-HT2 and Beta-Adrenergic-Receptor Binding-Sites in the Brain of Suicide Victims. Arch. Gen. Psychiatry. 1990;47:1038–1047. doi: 10.1001/archpsyc.1990.01810230054009.
    1. Mann JJ, et al. A serotonin transporter gene promoter polymorphism (5-HTTLPR) and prefrontal cortical binding in major depression and suicide. Arch. Gen. Psychiatry. 2000;57:729–738. doi: 10.1001/archpsyc.57.8.729.
    1. Oquendo MA, et al. Higher postmortem prefrontal 5-HT2A receptor binding correlates with lifetime aggression in suicide. Biol. Psychiatry. 2006;59:235–243. doi: 10.1016/j.biopsych.2005.06.037.
    1. Underwood MD, Mann JJ, Huang YY, Arango V. Family history of alcoholism is associated with lower 5-HT2A receptor binding in the prefrontal cortex. Alcohol. Clin. Exp. Res. 2008;32:593–599. doi: 10.1111/j.1530-0277.2007.00610.x.
    1. Kelly TM, Mann JJ. Validity of DSM-III-R diagnosis by psychological autopsy: a comparison with clinician ante-mortem diagnosis. Acta Psychiatr. Scand. 1996;94:337–343. doi: 10.1111/j.1600-0447.1996.tb09869.x.
    1. Spitzer, R. L., Williams, J. B. W., Gibbon, M. & First, M. B. Instruction Manual for the Structured Clinical Interview for DSM-III-R (SCID, 5/1/89 Revision). (Biometrics Research Department, New York State Psychiatric Institute: New York, 1989).
    1. Brown GL, Goodwin FK, Ballenger JC, Goyer PF, Major LF. Aggression in humans correlates with cerebrospinal fluid amine metabolites. Psychiatry Res. 1979;1:131–139. doi: 10.1016/0165-1781(79)90053-2.
    1. Hoyer D, Pazos A, Probst A, Palacios JM. Serotonin receptors in the human brain. I. Characterization and autoradiographic localization of 5-HT1A recognition sites. Apparent absence of 5-HT1B recognition sites. Brain Res. 1986;376:85–96. doi: 10.1016/0006-8993(86)90902-9.
    1. Arango, V. & Mann, J. J. in Neurobiology of Mental Illness, 3rd edn (eds Charney, D. & Nestler E. J) 515–529 (Oxford University Press: Oxford, UK, 2009).
    1. Stockmeier CA. Involvement of serotonin in depression: evidence from postmortem and imaging studies of serotonin receptors and the serotonin transporter. J. Psychiatr. Res. 2003;37:357–373. doi: 10.1016/S0022-3956(03)00050-5.
    1. Parsey RV, et al. Acute occupancy of brain serotonin transporter by sertraline as measured by [C-11]DASB and positron emission tomography. Biol. Psychiatry. 2006;59:821–828. doi: 10.1016/j.biopsych.2005.08.010.
    1. Parsey RV, et al. Metabolite considerations in the in vivo quantification of serotonin transporters using 11C-DASB and PET in humans. J. Nucl. Med. 2006;47:1796–1802.
    1. Cannon DM, et al. Elevated serotonin transporter binding in major depressive disorder assessed using positron emission tomography and [11C]DASB; comparison with bipolar disorder. Biol. Psychiatry. 2007;62:870–877. doi: 10.1016/j.biopsych.2007.03.016.
    1. Mantere T, et al. Serotonin transporter distribution and density in the cerebral cortex of alcoholic and nonalcoholic comparison subjects: a whole-hemisphere autoradiography study. Am. J. Psychiatry. 2002;159:599–606. doi: 10.1176/appi.ajp.159.4.599.
    1. Thompson PM, Cruz DA, Olukotun DY, Delgado PL. Serotonin receptor, SERT mRNA and correlations with symptoms in males with alcohol dependence and suicide. Acta Psychiatr. Scand. 2012;126:165–174. doi: 10.1111/j.1600-0447.2011.01816.x.
    1. Szabo Z, et al. Positron emission tomography imaging of the serotonin transporter in subjects with a history of alcoholism. Biol. Psychiatry. 2004;55:766–771. doi: 10.1016/j.biopsych.2003.11.023.
    1. Brown AK, et al. PET [11C]DASB imaging of serotonin transporters in patients with alcoholism. Alcohol.: Clin. Exp. Res. 2007;31:28–32. doi: 10.1111/j.1530-0277.2006.00261.x.
    1. Martinez D, et al. Positron emission tomography imaging of the serotonin transporter and 5-HT(1A) receptor in alcohol dependence. Biol. Psychiatry. 2009;65:175–180. doi: 10.1016/j.biopsych.2008.08.034.
    1. Matsubara S, Arora RC, Meltzer HY. Serotonergic measures in suicide brain: 5-HT1A binding sites in frontal cortex of suicide victims. J. Neural Transm. Gen. Sect. 1991;85:181–194. doi: 10.1007/BF01244944.
    1. Joyce JN, et al. Serotonin uptake sites and serotonin receptors are altered in the limbic system of schizophrenics. Neuropsychopharmacology. 1993;8:315–336. doi: 10.1038/npp.1993.32.
    1. Parsey RV, et al. Higher 5-HT(1A) receptor binding potential during a major depressive episode predicts poor treatment response: preliminary data from a naturalistic study. Neuropsychopharmacology. 2006;31:1745–1749. doi: 10.1038/sj.npp.1300992.
    1. Dillon KA, Gross-Isseroff R, Israeli M, Biegon A. Autoradiographic analysis of serotonin 5-HT1A receptor binding in the human brain postmortem: effects of age and alcohol. Brain Res. 1991;554:56–64. doi: 10.1016/0006-8993(91)90171-Q.
    1. Arranz B, Eriksson A, Mellerup E, Plenge P, Marcusson J. Brain 5-HT1A, 5-HT1D, and 5-HT2 receptors in suicide victims. Biol. Psychiatry. 1994;35:457–463. doi: 10.1016/0006-3223(94)90044-2.
    1. Lowther S, et al. 5-HT1A receptor binding sites in post-mortem brain samples from depressed suicides and controls. J. Affect Disord. 1997;42:199–207. doi: 10.1016/S0165-0327(96)01413-9.
    1. Stockmeier CA, et al. Serotonin receptors in suicide victims with major depression. Neuropsychopharmacology. 1997;16:162–173. doi: 10.1016/S0893-133X(96)00170-4.
    1. Stockmeier CA, et al. Antagonist but not agonist labeling of serotonin-1A receptors is decreased in major depressive disorder. J. Psychiatr. Res. 2009;43:887–894. doi: 10.1016/j.jpsychires.2009.01.001.
    1. Storvik M, Hakkinen M, Tupala E, Tiihonen J. 5-HT(1A) receptors in the frontal cortical brain areas in Cloninger type 1 and 2 alcoholics measured by whole-hemisphere autoradiography. Alcohol. Alcohol. 2009;44:2–7. doi: 10.1093/alcalc/agn090.
    1. Parsey RV, et al. Higher serotonin 1A binding in a second major depression cohort: modeling and reference region considerations. Biol. Psychiatry. 2010;68:170–178. doi: 10.1016/j.biopsych.2010.03.023.
    1. Hirvonen J, et al. Decreased brain serotonin 5-HT1A receptor availability in medication-naive patients with major depressive disorder: an in-vivo imaging study using PET and [carbonyl-11C]WAY-100635. Int. J. Neuropsychopharmacol. 2008;11:465–476. doi: 10.1017/S1461145707008140.
    1. Drevets WC, et al. PET imaging of serotonin 1A receptor binding in depression. Biol. Psychiatry. 1999;46:1375–1387. doi: 10.1016/S0006-3223(99)00189-4.
    1. Sargent PA, et al. Brain serotonin1A receptor binding measured by positron emission tomography with [11C]WAY-100635: effects of depression and antidepressant treatment. Arch. Gen. Psychiatry. 2000;57:174–180. doi: 10.1001/archpsyc.57.2.174.
    1. Le Francois B, et al. Chronic mild stress and antidepressant treatment alter 5-HT1A receptor expression by modifying DNA methylation of a conserved Sp4 site. Neurobiol. Dis. 2015;82:332–341. doi: 10.1016/j.nbd.2015.07.002.
    1. Turecki G, et al. Prediction of level of serotonin 2A receptor binding by serotonin receptor 2A genetic variation in postmortem brain samples from subjects who did or did not commit suicide. Am. J. Psychiatry. 1999;156:1456–1458.
    1. Pandey GN, et al. Higher expression of serotonin 5-HT(2A) receptors in the postmortem brains of teenage suicide victims. Am. J. Psychiatry. 2002;159:419–429. doi: 10.1176/appi.ajp.159.3.419.
    1. Gross-Isseroff R, Salama D, Israeli M, Biegon A. Autoradiographic analysis of [3H]ketanserin binding in the human brain postmortem: effect of suicide. Brain Res. 1990;507:208–215. doi: 10.1016/0006-8993(90)90274-F.
    1. Erritzoe D, et al. Brain serotonin 2A receptor binding: relations to body mass index, tobacco and alcohol use. Neuroimage. 2009;46:23–30. doi: 10.1016/j.neuroimage.2009.01.050.
    1. Pandey, G. N. et al. in Contemporary Neuropsychiatry (eds Miyoshi, K., Shapiro, C. M., Gaviria M. & Morita Y) 314–321 (Springer-Verlag: Tokyo, 2001).
    1. Miller JM, et al. Reported childhood abuse is associated with low serotonin transporter binding in vivo in major depressive disorder. Synapse. 2009;63:565–573. doi: 10.1002/syn.20637.
    1. Gartside SE, Johnson DA, Leitch MM, Troakes C, Ingram CD. Early life adversity programs changes in central 5-HT neuronal function in adulthood. Eur. J. Neurosci. 2003;17:2401–2408. doi: 10.1046/j.1460-9568.2003.02668.x.
    1. Spinelli S, et al. Effects of early-life stress on serotonin(1A) receptors in juvenile Rhesus monkeys measured by positron emission tomography. Biol. Psychiatry. 2010;67:1146–1153. doi: 10.1016/j.biopsych.2009.12.030.
    1. Heim C, Binder EB. Current research trends in early life stress and depression: review of human studies on sensitive periods, gene-environment interactions, and epigenetics. Exp. Neurol. 2012;233:102–111. doi: 10.1016/j.expneurol.2011.10.032.
    1. Turecki G. Early-Life Adversity and Suicide Risk: The Role of Epigenetics. In: Pompili M (ed). Phenomenology of Suicide. Springer, Cham, Switzerland. 2018.
    1. Brown GW, Harris TO. Depression and the serotonin transporter 5-HTTLPR polymorphism: a review and a hypothesis concerning gene-environment interaction. J. Affect Disord. 2008;111:1–12. doi: 10.1016/j.jad.2008.04.009.
    1. Zalsman G, et al. Association of a triallelic serotonin transporter gene promoter region (5-HTTLPR) polymorphism with stressful life events and severity of depression. Am. J. Psychiatry. 2006;163:1588–1593. doi: 10.1176/ajp.2006.163.9.1588.
    1. Roy A, Hu XZ, Janal MN, Goldman D. Interaction between childhood trauma and serotonin transporter gene variation in suicide. Neuropsychopharmacology. 2007;32:2046–2052. doi: 10.1038/sj.npp.1301331.
    1. Wankerl M, et al. Effects of genetic and early environmental risk factors for depression on serotonin transporter expression and methylation profiles. Transl. Psychiatry. 2014;4:e402. doi: 10.1038/tp.2014.37.
    1. Chipman P, Jorm AF, Tan XY, Easteal S. No association between the serotonin-1A receptor gene single nucleotide polymorphism rs6295C/G and symptoms of anxiety or depression, and no interaction between the polymorphism and environmental stressors of childhood anxiety or recent stressful life events on anxiety or depression. Psychiatr. Genet. 2010;20:8–13. doi: 10.1097/YPG.0b013e3283351140.
    1. Bukh JD, et al. Interaction between genetic polymorphisms and stressful life events in first episode depression. J. Affect Disord. 2009;119:107–115. doi: 10.1016/j.jad.2009.02.023.
    1. Weissman MM, Klerman GL. Sex differences and the epidemiology of depression. Arch. Gen. Psychiatry. 1977;34:98–111. doi: 10.1001/archpsyc.1977.01770130100011.
    1. Oquendo MA, et al. Sex differences in clinical predictors of suicidal acts after major depression: a prospective study. Am. J. Psychiatry. 2007;164:134–141. doi: 10.1176/ajp.2007.164.1.134.
    1. Cloninger CR, Christiansen KO, Reich T. Gottesman, II. Implications of sex differences in the prevalences of antisocial personality, alcoholism, and criminality for familial transmission. Arch. Gen. Psychiatry. 1978;35:941–951. doi: 10.1001/archpsyc.1978.01770320035002.
    1. Cosgrove KP, Mazure CM, Staley JK. Evolving knowledge of sex differences in brain structure, function, and chemistry. Biol. Psychiatry. 2007;62:847–855. doi: 10.1016/j.biopsych.2007.03.001.
    1. Jovanovic H, et al. Sex differences in the serotonin 1A receptor and serotonin transporter binding in the human brain measured by PET. Neuroimage. 2008;39:1408–1419. doi: 10.1016/j.neuroimage.2007.10.016.
    1. Parsey RV, et al. Effects of sex, age, and aggressive traits in man on brain serotonin 5-HT1A receptor binding potential using [11C]WAY-100635. Neuroimage. 2002;16:S106–S106.
    1. Soloff PH, Price JC, Mason NS, Becker C, Meltzer CC. Gender, personality, and serotonin-2A receptor binding in healthy subjects. Psychiatry Res. 2010;181:77–84. doi: 10.1016/j.pscychresns.2009.08.007.
    1. Adams KH, et al. A database of [(18)F]-altanserin binding to 5-HT(2A) receptors in normal volunteers: normative data and relationship to physiological and demographic variables. Neuroimage. 2004;21:1105–1113. doi: 10.1016/j.neuroimage.2003.10.046.
    1. Stein P, et al. The serotonin-1A receptor distribution in healthy men and women measured by PET and [carbonyl-11C]WAY-100635. Eur. J. Nucl. Med. Mol. Imaging. 2008;35:2159–2168. doi: 10.1007/s00259-008-0850-x.
    1. Kovachich GB, Aronson CE, Brunswick DJ, Frazer A. Quantitative autoradiography of serotonin uptake sites in rat brain using 3H-cyanoimipramine. Brain Res. 1988;454:78–88. doi: 10.1016/0006-8993(88)90805-0.
    1. Underwood MD, Arango V. Evidence for Neurodegeneration and Neuroplasticity as Part of the Neurobiology of Suicide. Biol. Psychiatry. 2011;70:306–307. doi: 10.1016/j.biopsych.2011.06.004.
    1. Sprouse JS, Aghajanian GK. -)-Propranolol blocks the inhibition of serotonergic dorsal raphe cell firing by 5-HT1A selective agonists. Eur. J. Pharmacol. 1986;128:295–298. doi: 10.1016/0014-2999(86)90782-X.
    1. Stahl S. 5HT1A receptors and pharmacotherapy. Is serotonin receptor down-regulation linked to the mechanism of action of antidepressant drugs? Psychopharmacol. Bull. 1994;30:39–43.
    1. Blakely RD, et al. Regulated phosphorylation and trafficking of antidepressant-sensitive serotonin transporter proteins. Biol. Psychiatry. 1998;44:169–178. doi: 10.1016/S0006-3223(98)00124-3.
    1. Hensler JG. Regulation of 5-HT1A receptor function in brain following agonist or antidepressant administration. Life. Sci. 2003;72:1665–1682. doi: 10.1016/S0024-3205(02)02482-7.
    1. Behm M, Ohman M. RNA editing: a contributor to neuronal dynamics in the mammalian brain. Trends Genet. 2016;32:165–175. doi: 10.1016/j.tig.2015.12.005.
    1. Leiser SC, et al. Serotonergic regulation of prefrontal cortical circuitries involved in cognitive processing: a review of individual 5-HT receptor mechanisms and concerted effects of 5-HT receptors exemplified by the multimodal antidepressant vortioxetine. ACS Chem. Neurosci. 2015;6:970–986. doi: 10.1021/cn500340j.
    1. Aznar S, Hervig Mel S. The 5-HT2A serotonin receptor in executive function: Implications for neuropsychiatric and neurodegenerative diseases. Neurosci. Biobehav. Rev. 2016;64:63–82. doi: 10.1016/j.neubiorev.2016.02.008.
    1. Wirth A, Holst K, Ponimaskin E. How serotonin receptors regulate morphogenic signalling in neurons. Prog. Neurobiol. 2017;151:35–56. doi: 10.1016/j.pneurobio.2016.03.007.
    1. Burton CZ, Vella L, Weller JA, Twamley EW. Differential effects of executive functioning on suicide attempts. J. Neuropsychiatry Clin. Neurosci. 2011;23:173–179. doi: 10.1176/jnp.23.2.jnp173.
    1. Saffer BY, Klonsky ED. Do neurocognitive abilities distinguish suicide attempters from suicide ideators? A systematic review of an emerging research area. Clin. Psychol.: Sci. Pract. 2018;25:1.
    1. Olie E, et al. Processing of decision-making and social threat in patients with history of suicidal attempt: a neuroimaging replication study. Psychiatry Res. 2015;234:369–377. doi: 10.1016/j.pscychresns.2015.09.020.
    1. Ding Y, et al. Prefrontal cortex markers of suicidal vulnerability in mood disorders: a model-based structural neuroimaging study with a translational perspective. Transl. Psychiatry. 2015;5:e516. doi: 10.1038/tp.2015.1.
    1. Korgaonkar MS, Fornito A, Williams LM, Grieve SM. Abnormal structural networks characterize major depressive disorder: a connectome analysis. Biol. Psychiatry. 2014;76:567–574. doi: 10.1016/j.biopsych.2014.02.018.
    1. Singh MK, et al. Anomalous gray matter structural networks in major depressive disorder. Biol. Psychiatry. 2013;74:777–785. doi: 10.1016/j.biopsych.2013.03.005.
    1. Ferrer I, Martinez A, Boluda S, Parchi P, Barrachina M. Brain banks: benefits, limitations and cautions concerning the use of post-mortem brain tissue for molecular studies. Cell Tissue Bank. 2008;9:181–194. doi: 10.1007/s10561-008-9077-0.
    1. Fowler CJ, Cowburn RF, Hardy JA, Wester P, Winblad B. Neurotransmitter Function in Post-Mortem Human Brain: An Overview. Springer Berlin Heidelberg: Berlin, Heidelberg, 1990, pp 668-674.
    1. McCullumsmith RE, Meador-Woodruff JH. Novel approaches to the study of postmortem brain in psychiatric illness: old limitations and new challenges. Biol. Psychiatry. 2011;69:127–133. doi: 10.1016/j.biopsych.2010.09.035.
    1. Joo SH, et al. Factors associated with suicide completion: a comparison between suicide attempters and completers. Asia Pac. Psychiatry. 2016;8:80–86. doi: 10.1111/appy.12216.
    1. Davis FB. Relationship between suicide and attempted suicide - a review of literature. Psychiatr. Q. 1967;41:752-+. doi: 10.1007/BF01575635.
    1. Younes N, et al. Attempted and completed suicide in primary care: not what we expected? J. Affect Disord. 2015;170:150–154. doi: 10.1016/j.jad.2014.08.037.
    1. Mathew DC, et al. Neurobiological aspects of suicide and suicide attempts in bipolar disorder. Transl Neurosci. 2013;4:203–216.
    1. Pandey GN. Biological basis of suicide and suicidal behavior. Bipolar Disord. 2013;15:524–541. doi: 10.1111/bdi.12089.
    1. Balcioglu YH, Kose S. Neural substrates of suicide and suicidal behaviour: from a neuroimaging perspective. Psychiatry Clin. Psychopharmacol. 2018;0:1–15.

Source: PubMed

3
订阅